(Q40385113)
Statements
The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth (English)
Michael Steiner
Vladimir Gavrilov
scientific article published on September 2005
No description defined